ロード中...
Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Ciprofloxacin, the first fluoroquinolone to be used to treat lower respiratory tract infections (LRTI), demonstrates poor potency against Streptococcus pneumoniae, and its use has been associated with the emergence of resistance. During the last decade, fluoroquinolones with enhanced in vitro activi...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3147653/ https://ncbi.nlm.nih.gov/pubmed/21628545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00237-11 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|